GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027

GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027

The global exosome diagnostic and therapeutic market is anticipated to generate revenue of $582.45 million by 2027 and to grow at a CAGR of 27.72% between 2019 and 2027. Exosomes are defined as cell-derived vesicles that are present in all biological fluids, such as blood and urine. The exosome diagnostic and therapeutic market is primarily driven by the following factors:

GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027

Global Exosome Diagnostic and Therapeutic Market by Application (Diagnostic,therapeutic) by Product (Instrument, Reagent, Software) by End-user (Cancer Institute, Hospital, Diagnostic Center, Other End-user) by Geography.

Request free sample

The global exosome diagnostic and therapeutic market is anticipated to generate revenue of $582.45 million by 2027 and to grow at a CAGR of 27.72% between 2019 and 2027. Exosomes are defined as cell-derived vesicles that are present in all biological fluids, such as blood and urine. The exosome diagnostic and therapeutic market is primarily driven by the following factors:

  • Increase in the pervasiveness of cancer
  • Rising government and non-government initiatives
  • Advancement in technology

The important drivers that are increasing the growth of the global exosome diagnostic and therapeutic market have been the advancement in technology, and an increase in the pervasiveness of cancer. Exosomes are nano-vesicles that comprise the proteins, DNA and RNA, which creates huge potential in the exosomes for the diagnosis of cancer. Introduction of innovative and technologically advanced exosome isolation procedures and isolation kits attract healthcare professionals and scientists to use exosome-based diagnostic and therapeutic products for their medical practices.

The application and products of exosome diagnostic and therapeutic market are used extensively for various purposes. The application comprises of diagnostic and therapeutic. Exosome-based diagnostics procedures use exosome as a biomarker for the diagnosis and progression of cancer. Some of the major exosome therapeutics includes regenerative capabilities, especially in the case of myocardial regeneration to repair cardiac tissues. Products of exosome diagnostic and therapeutic comprises of instrument, reagent, and software. Increasing research on exosome is the key driving factor for the global exosome instrument market. Reagents are used in isolation and culturing of exosomes in research and diagnostic laboratories. Innovative and advanced applications of exosome software in gene sequencing analysis have fueled the demand for this software across healthcare facilities.

Challenges faced in the usage of exosome and stringent regulation are the major factors hindering the exosome diagnostic and therapeutic market. The clinical development of exosomes as a “first-in-class” drug has a highly tractable manufacturing challenge. In the current scenario, the stringent regulatory standards affect the exosome diagnostic and therapeutic market growth, as it is a mandate to follow all regulatory standards.

The global exosome diagnostic and therapeutic market segments include application, product and end-user.

Application is segmented into:

  • Diagnostic
  • Therapeutic

Product is segmented into:

  • Instrument
  • Reagent
  • Software

End-user is segmented into:

  • Cancer Institute
  • Hospital
  • Diagnostic center
  • Other End-user

This report covers the present market conditions and the growth prospects of the global exosome diagnostic and therapeutic market for 2019-2027 forecasting period and considered the revenue generated through the sales of exosome diagnostic and therapeutic for application, product and end-user to calculate the market size by considering 2018 as the base year.

Geographically, the global exosome diagnostic and the therapeutic market have been segmented on the basis of four major regions, which are:

The exosome diagnostic and therapeutic market in North America is expected to hold the largest share by 2027 possibilities of increased use of Exosome diagnostic and therapeutic. North America exosome diagnostic and therapeutic market constitutes approximately 41% share. The U.S. is the largest market in North America and is expected to maintain this trend during the analysis period. This is due to well-developed healthcare infrastructure in the region, technological advancement in exosome isolation techniques, and the significant increase in the geriatric population. On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the exosome diagnostic and therapeutic market.

The Asia-Pacific region includes Japan, China, India, Australia, South Korea, and other countries. Increase in demand for advanced healthcare services in the emerging economies, such as that of India and China, is the major factor driving the growth of the Asia-Pacific regional market. In addition, the increase in the prevalence of cancer and cardiac diseases coupled with a rise in population in these nations are expected to fuel the demand for exosome-based diagnostic procedures.

The exosome diagnostic and therapeutic market is segmented based on end-user which is sub-divided into cancer institute, hospital, diagnostic center, and other end-user. Cancer institutes are expected to be a leading end-user segment in the exosome therapeutic and diagnostic market. In hospitals, exosome-based devices are used in the diagnosis and management of various diseases. In the diagnosis and treatment of chronic diseases, exosomes play a significant role, as exosomes may promote the development or progression of chronic inflammatory lung diseases such as asthma, pulmonary fibrosis, and chronic obstructive pulmonary disease. Other end-users of exosome diagnostic & therapeutic products include pharmaceutical and life science industries, medical universities, nursing homes, and non-profit organizations. Biotech companies are widely adopting exosomes for delivering many types of molecules, such as proteins and nucleic acid, and as therapies.

The major market players of the global exosome diagnostic and therapeutic market are:

  • Aethlon Medical, Inc.
  • Exosome Diagnostics Inc.
  • Hitachi Chemical Diagnostics, Inc.
  • Qiagen N.V.
  • Nanosomix Inc.

Company Profiles covers the analysis of important players. Aethlon Medical, Inc. is highly focused on the discovery of biomarkers based on exosomes to diagnose and monitor neurological diseases and cancer. The company focuses on the neurodegeneration market.

Nanosomix Inc.’s first assay, NSX Direct, uses neural-derived exosomes to detect elevated levels of two key proteins involved in the pathogenesis of AD (p-tau and amyloid beta).

Key findings of the global exosome diagnostic and therapeutic market:

  • The diagnostic is the majorly used application
  • The software segment is anticipated to grow at a significant rate
  • Cancer institute’s hold the largest market share in terms of end-user
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • DIAGNOSTIC IS THE MAJORLY USED APPLICATION
      • SOFTWARE SEGMENT IS ANTICIPATED TO GROW AT A SIGNIFICANT RATE
      • CANCER INSTITUTES HOLD THE LARGEST MARKET SHARE IN TERMS OF END-USER
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • INCREASE IN PERVASIVENESS OF CANCER
      • RISING GOVERNMENT AND NON GOVERNMENT INITIATIVES
      • ADVANCEMENT IN TECHNOLOGY
    • MARKET RESTRAINTS
      • CHALLENGES FACED IN THE USAGE OF EXOSOME
      • STRINGENT REGULATION
    • MARKET OPPORTUNITIES
      • LUCRATIVE GROWTH OPPORTUNITIES IN THE EMERGING ECONOMIES
      • INCREASE IN ADOPTION OF INNOVATIVE AND ADVANCED EXOSOME DIAGNOSTIC AND THERAPEUTIC PROCEDURES
    • MARKET CHALLENGES
      • LOW AWARENESS IN THE DEVELOPING COUNTRIES
  1. MARKET BY APPLICATION
    • DIAGNOSTIC
    • THERAPEUTIC
  2. MARKET BY PRODUCT
    • INSTRUMENT
    • REAGENT
    • SOFTWARE
  3. MARKET BY END-USER
    • CANCER INSTITUTE
    • HOSPITAL
    • DIAGNOSTIC CENTER
    • OTHER END-USER
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • EXOSOME ETYMOLOGY
    • PATENT ANALYSIS
    • COMPONENTS OF EXOSOME
    • OPPORTUNITY MATRIX
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • COMPANY PROFILES
      • AETHLON MEDICAL, INC.
      • BIOCAT GMBH
      • CAPRICOR THERAPEUTICS, INC.
      • CODIAK BIOSCIENCES
      • EVOX THERAPEUTICS LTD.
      • EXOSOME DIAGNOSTICS INC.
      • HANSABIOMED LIFE SCIENCES LTD. (ACQUIRED BY LONZA)
      • HITACHI CHEMICAL DIAGNOSTICS, INC.
      • MALVERN INSTRUMENTS LTD.
      • MBL INTERNATIONAL CORPORATION
      • NANOSOMIX INC.
      • SISTEMIC LTD.
      • SYSTEM BIOSCIENCES (SBI)
      • THERMO FISHER SCIENTIFIC INC.
      • QIAGEN N.V.

LIST OF TABLE

TABLE 1        NOMENCLATURE OF EXOSOME PARTICLES

TABLE 2        GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 3        GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 4        GLOBAL DIAGNOSTIC MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 5        GLOBAL THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 6        GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 7        GLOBAL INSTRUMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 8        COMMERCIAL KITS AND REAGENTS EXAMPLES FOR THE ISOLATION OF EXOSOME

TABLE 9        GLOBAL REAGENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 10      GLOBAL SOFTWARE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 11      GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 12      GLOBAL CANCER INSTITUTE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13      GLOBAL HOSPITAL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 14      EXOSOME ASSOCIATED PROTEIN IN CLINICAL DIAGNOSTICS USAGE

TABLE 15      GLOBAL DIAGNOSTIC CENTER MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 16      GLOBAL OTHER END-USER MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 17      TYPE OF PROTEINS FOUND IN EXOSOMES

TABLE 18      GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 20      EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 21      ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 22      ESTIMATED MOST COMMON CANCERS DIAGNOSED IN AUSTRALIA 2017

TABLE 23      REST OF WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)

LIST OF FIGURE

FIGURE 1      GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 2      GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 3      GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC 2019-2027 ($ MILLION)

FIGURE 4      GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)

FIGURE 5      GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY PRODUCT 2018 & 2027 (%)

FIGURE 6      GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY INSTRUMENT 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REAGENT  2019-2027 ($ MILLION)

FIGURE 8      GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY SOFTWARE 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY END-USER 2018 & 2027 (%)

FIGURE 10   NUMBER OF PEOPLE WITH CANCER GLOBALLY 2005-2016 (MILLIONS)

FIGURE 11   GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY CANCER INSTITUTE 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY HOSPITAL 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC CENTER 2019-2027 ($ MILLION)

FIGURE 14   INCIDENCE OF PATIENTS WITH CHRONIC DISEASES GLOBALLY 2005-2030 (MILLIONS)

FIGURE 15   GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY OTHER END-USER 2019-2027 ($ MILLION)

FIGURE 16   PORTER’S FIVE FORCE MODEL

FIGURE 17   NUMBER OF PAPERS PUBLISHED ON EXOSOME 2003-2017

FIGURE 18   GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 19   THE UNITED STATES EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 20   CANADA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 21   GERMANY EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 22   FRANCE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 23   THE UNITED KINGDOM EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 24   ITALY EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 25   SPAIN EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 26   REST OF EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 27   JAPAN EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 28   CHINA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 29   INDIA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 30   AUSTRALIA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 31   SOUTH KOREA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 32   REST OF ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 33   LATIN AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 34   MIDDLE EAST AND AFRICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

  1. MARKET BY APPLICATION
    • DIAGNOSTIC
    • THERAPEUTIC
  2. MARKET BY PRODUCT
    • INSTRUMENT
    • REAGENT
    • SOFTWARE
  3. MARKET BY END-USER
    • CANCER INSTITUTE
    • HOSPITAL
    • DIAGNOSTIC CENTER
    • OTHER END-USER
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now